Navigation Links
Boffins Identify Gene That Helps Regulates Body Weight

Boffins have found that the absence of CD38 gene prevented mice on high-fat diets from gaining weight.

The study was conducted by a team of researchers led by Eduardo Chini at Mayo Clinic.

As part of the study, researchers studied two groups of mice - one with the gene CD38 and the other without. Each group was fed a high-calorie diet with 60 percent of calories from fat. In a second test, each group was fed a standard diet in which 4 percent of calories came from fat.

Researchers found that the body fat of mice that carried CD38 and were on a high-fat diet nearly quadrupled and their body weight almost doubled. After eight weeks on a high-fat diet, mice with CD38 began to show signs of glucose intolerance, one of the first indicators of diabetes onset.

In addition, this group of mice lived for only four-to-six months compared to the second group of mice that lived for 12 months.

The study noted that for the group of mice that had no CD38, the body fat and weight did not change even though they were on a high fat diet. These mice burned more energy, were leaner and otherwise healthy. he researchers also examined the effects of resveratrol in mice.

Resveratrol is a naturally occurring substance found in some plants such as mulberries, peanuts and red grapes used to make wine. It has been marketed as a drug that mimics the effects of moderate exercise without the physical act of exercising and also as a longevity drug, despite the lack of evidence that resveratrol is safe and effective in humans.

Researchers treated mice with CD38 with 30 milligrams of resveratrol per day and to determine the effects of the SIRT genes on obesity, mice without CD38 received the same dose of sirtinol, a drug that shuts down the SIRT genes.

Researchers found that mice with CD38 that were treated with resveratrol for two weeks were protected from high-fat, diet-induced obesit y. By contrast, the protective effect against high-fat, diet-induced obesity in the absence of CD38 in mice was invalidated by sirtinol.

Mice without CD38 that were treated with sirtinol gained a statistically significant amount of weight when compared with mice without the gene who were not treated with sirtinol.

"Together these results identify a novel pathway regulating body weight and clearly show that CD38 is a nearly obligatory component of the cellular cascade that led to diet-induced obesity," the authors write.

The findings of the study were published in the online issue of The FASEB Journal, the journal of the Federation of American Societies for Experimental Biology. The study will appear in the November 2007 print issue of the journal.


'"/>




Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Boffins Find Link Between Common Sleep Disorder and Hypertension
4. Boffins Identify Molecule That Might Treat Food Allergy
5. Boffins a Step Closer to Solving Puzzle of Lou Gehrigs Disease
6. Boffins Link Atkins Diet With Bowel Cancer
7. Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA
8. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
9. Identifying bacteria made amiable
10. Identifying brain lesions with impaired consciousness
11. Identifying Virus Found To Be Essential for HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it will be co-hosting a workshop ... excipients and drug delivery solutions to health industries worldwide. The one day event ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is proud to ... workflow designed to seamlessly integrate and streamline the way researchers prepare and conduct ... maximizing usability and improving efficiency significantly for users – a first in the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... offering treatments for patients with sleep apnea and TMJ disorders. These conditions are ... physical health. Dr. Rassouli provides personalized care to reduce the risk of these ...
(Date:1/19/2017)... ... ... Allegheny Health Network (AHN) officials today announced a bold new step to greatly ... in the greater Pittsburgh region. Starting January 23, patients who call AHN by 11 ... afternoon. , AHN is the first healthcare provider in the region ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 ... Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to ... from touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. ... a federal institution supporting research in Germany ... and patient treatments at the University Clinic Heidelberg as ... The MRIdian Linac program will be headed by ... also heads radiation oncology at the German Cancer Research ...
(Date:1/19/2017)... Jan. 19, 2017   Science Exchange , the ... announce that the first five replication studies from ... been published in eLife today. Despite intense scrutiny ... first practical evaluation of reproducibility rates that may ... Unlike other assessments of reproducibility, the results of ...
Breaking Medicine Technology: